Skip to content

Treatment of infertility in Ayurveda

MANAGEMENT OF FEMALE INFERTILITY WSR TO TUBAL BLOCKAGE BY UTTARBASTI WITH APAMARGA KSHARA TAILA and PHALAKALYANA GHRITA

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/01/007664
Enrollment
30
Registered
2017-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Tubal factor in Female Infertility

Interventions

Intervention1: Intrauterine uttarbasti of Apamarga Ksharataila and Phalakalyana Ghrita: After deepan pachana and kostha shodhana then 5ml uttarabasti of apamarga ksharataila for 3 days then 3 days Gap

Sponsors

IPGT and RA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients of childbearing age (20-37yrs) with active marital life of 1 year or more, having complaint of failure to conceive with at least one fallopian Tube blocked diagnosed by H.S.G. 2 Having seminogram within normal limit of male partner.( >20 million/ml)

Exclusion criteria

Exclusion criteria: 1 Patients having age group below 20 years & above 37 years 2 Patients having any acute pelvic infection, hypersensitivity to chemical dye, congenital anomalies of vulva & vagina, Ca cervix, STD or any debilitating disease like TB, HIV, VDRL, HBsAg and TORCH positive will be excluded from study 3)Patients suffering from infertility due to male factor ie Oligospermia, Oligozoospermia, Azoospermia, Asthanospermia also be excluded

Design outcomes

Primary

MeasureTime frame
Uttarabasti of Apamarga Kshara Taila and Phalkalyana Ghrita is highly effective in management of Female Infertility wsr to Tubal blockage.Timepoint: 3 month

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Shilpa Donga

IPGT and RA Gujarat Ayurved University Jamnagar

deilaxmipriya@yahoo.com9228198366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026